These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 18796605
1. Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Doiron AL, Chu K, Ali A, Brannon-Peppas L. Proc Natl Acad Sci U S A; 2008 Nov 11; 105(45):17232-7. PubMed ID: 18796605 [Abstract] [Full Text] [Related]
2. Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus. Zhang Y, Zhou J, Guo D, Ao M, Zheng Y, Wang Z. Int J Nanomedicine; 2013 Nov 11; 8():3745-56. PubMed ID: 24124363 [Abstract] [Full Text] [Related]
3. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking. Nkansah MK, Thakral D, Shapiro EM. Magn Reson Med; 2011 Jun 11; 65(6):1776-85. PubMed ID: 21404328 [Abstract] [Full Text] [Related]
4. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent. Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z. J Drug Target; 2011 Sep 11; 19(8):657-65. PubMed ID: 21091273 [Abstract] [Full Text] [Related]
5. Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent--a feasibility research. Ao M, Wang Z, Ran H, Guo D, Yu J, Li A, Chen W, Wu W, Zheng Y. J Biomed Mater Res B Appl Biomater; 2010 May 11; 93(2):551-6. PubMed ID: 20225249 [Abstract] [Full Text] [Related]
6. Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Ratzinger G, Agrawal P, Körner W, Lonkai J, Sanders HM, Terreno E, Wirth M, Strijkers GJ, Nicolay K, Gabor F. Biomaterials; 2010 Nov 11; 31(33):8716-23. PubMed ID: 20797782 [Abstract] [Full Text] [Related]
7. In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres. Faranesh AZ, Nastley MT, Perez de la Cruz C, Haller MF, Laquerriere P, Leong KW, McVeigh ER. Magn Reson Med; 2004 Jun 11; 51(6):1265-71. PubMed ID: 15170848 [Abstract] [Full Text] [Related]
8. A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors. Rigaux G, Roullin VG, Cadiou C, Portefaix C, Van Gulick L, Bœuf G, Andry MC, Hoeffel C, Vander Elst L, Laurent S, Muller R, Molinari M, Chuburu F. Nanotechnology; 2014 Nov 07; 25(44):445103. PubMed ID: 25325295 [Abstract] [Full Text] [Related]
9. Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Doiron AL, Homan KA, Emelianov S, Brannon-Peppas L. Pharm Res; 2009 Mar 07; 26(3):674-82. PubMed ID: 19034628 [Abstract] [Full Text] [Related]
10. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging. Li Q, Li C, Tong W. J Nanosci Nanotechnol; 2016 Jun 07; 16(6):5569-76. PubMed ID: 27427598 [Abstract] [Full Text] [Related]
11. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Yeh MK. J Microencapsul; 2000 Jun 07; 17(6):743-56. PubMed ID: 11063421 [Abstract] [Full Text] [Related]
12. Preparation of PLGA microparticles by an emulsion-extraction process using glycofurol as polymer solvent. Aubert-Pouëssel A, Venier-Julienne MC, Saulnier P, Sergent M, Benoît JP. Pharm Res; 2004 Dec 07; 21(12):2384-91. PubMed ID: 15648273 [Abstract] [Full Text] [Related]
13. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. Lück M, Pistel KF, Li YX, Blunk T, Müller RH, Kissel T. J Control Release; 1998 Nov 13; 55(2-3):107-20. PubMed ID: 9795026 [Abstract] [Full Text] [Related]
14. Synthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticles. Mooguee M, Omidi Y, Davaran S. J Pharm Sci; 2010 Aug 13; 99(8):3389-97. PubMed ID: 20229603 [Abstract] [Full Text] [Related]
15. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Pharm Res; 1999 Apr 13; 16(4):509-13. PubMed ID: 10227704 [Abstract] [Full Text] [Related]
17. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM, Kim SW. Pharm Res; 2004 Feb 13; 21(2):339-43. PubMed ID: 15032317 [Abstract] [Full Text] [Related]
18. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. O'Hara P, Hickey AJ. Pharm Res; 2000 Aug 13; 17(8):955-61. PubMed ID: 11028941 [Abstract] [Full Text] [Related]
19. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice. Fu D, Huang X, Lv Z, Zhang Y, Chen M, Zhang W, Su D. Bioengineered; 2022 Mar 13; 13(3):7105-7117. PubMed ID: 35259049 [Abstract] [Full Text] [Related]
20. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique. Zhu KJ, Jiang HL, Du XY, Wang J, Xu WX, Liu SF. J Microencapsul; 2001 Mar 13; 18(2):247-60. PubMed ID: 11253941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]